Rising burden of structural and congenital heart diseases and technological advancements in structural heart imaging modalities are expected to propel market growth.
Rising burden of structural and congenital heart diseases and technological advancements in structural heart imaging modalities are expected to propel market growth
The global structural heart imaging market size is expected to reach USD 34.1 billion in 2028 at a CAGR of 10.2%, according to a new report by Reports and Data. Steady market revenue growth is driven primarily by increasing prevalence of structural heart diseases as well as congenital heart diseases worldwide and technological advancements in structural heart imaging modalities. Rising awareness about cardiac health, prevalence of lifestyle-induced diseases including diabetes, high blood pressure, and obesity, and increasing unhealthy habits such as excessive alcohol and drug abuse are some other key factors driving growth of this market.
As an ever-evolving segment of cardiology, Structural Heart Imaging (SHI) addresses a wide range of heart conditions including valvular and non-valvular heart disease. This imaging technique involves the use of high-resolution cameras to screen the heart and produce distinct images of its interior parts. These images thus aid in the accurate diagnosis the cardiac condition of a patient. The commonly used structural heart imaging modalities are echocardiogram and angiogram (MRI, CT, etc.). These techniques are widely performed to assess the cardiac structure and identify narrowing or blockage of blood vessels. Transcatheter Aortic Valve Replacement (TAVR) is one of the most widely performed structural heart disease interventions. TAVR is minimally invasive and enables quicker recovery in patients, post-surgery. Furthermore, advances in TAVR techniques has fueled demand for structural heart intervention procedures globally, thereby propelling global market growth. Rising government support for R&D activities in the field of cardiology and increasing clinical trials of new cardiac imaging techniques is further opening up growth prospects in the market.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/4100
Some Key Highlights from the Report:
- Based on product type, the heart valve devices segment is the most dominant segment with the highest revenue share. Increasing number of TAVR procedures, advantages of procedure such as long-term durability and efficacy, and favorable regulatory policies for their use are key factors supporting growth of this segment.
- Based on imaging modality, the echocardiogram segment is expected to register fastest revenue growth rate over the forecast period. Growth of this segment is supported by surging prevalence of structural and congenital heart diseases worldwide, growing need for early and accurate diagnosis of these diseases, technological advancements in echocardiography procedures, and their increased usage in intraprocedural monitoring and postoperative follow-up.
- Among the regional markets, North America accounted to largest revenue share in 2020 and the trend is expected to continue over the forecast period. Growing healthcare burden of structural and congenital heart diseases, surging demand for state-of-the-art diagnostic solutions, increase in awareness programs about cardiac health, and increasing government efforts to improve healthcare accessibility in countries in the region are among some major factors driving North America market growth.
- Siemens Healthineers GmbH, Koninklijke Philips N.V., Toshiba Corporation, Boston Scientific Corporation, CryoLife, Inc., Medtronic Plc, CardioComm Solutions Inc., Abbott Laboratories, LivaNova PLC, Edwards Lifesciences Corporation, Circle Cardiovascular Imaging, Inc., HeartSciences, TomTec Imaging Systems GmbH, Lepu Medical Technology Co., Micro Interventional Devices, Inc., Braile Biomédica, Shimadzu Corporation, Ltd., Pie Medical Imaging B.V., TTK Healthcare Limited, 3mensio Medical Imaging BV, Integer Holdings Corporation, and Aran Biomedical Teoranta are some of the key players in the global structural heart imaging market.
Buy now your Exclusive copy of Report @ https://www.reportsanddata.com/checkout-form/4100
For the purpose of this report, the global structural heart imaging market has been segmented based on the product type, imaging modality, procedure type, application, and region:
By Product Type (Revenue, USD Billion; 2018-2028)
- Heart Valve Devices
- Transcatheter Heart Valves
- Surgical Heart Valves
- Occluders and Delivery Systems
- Annuloplasty Rings
- Others
By Imaging Modality (Revenue, USD Billion; 2018-2028)
- Echocardiogram
- Angiogram
- MRI (Magnetic Resonance Imaging)
- CT (Computed Tomography)
By Procedure Type (Revenue, USD Billion; 2018-2028)
- Transcatheter Aortic Valve Replacement (TAVR)
- Surgical Aortic Valve Replacement (SAVR)
- Transcatheter Mitral Valve Repair (TMVR)
- Left Atrial Appendage Closure (LAAC)
- Annuloplasty
- Valvuloplasty
- Others
By Application (Revenue, USD Billion; 2018-2028)
- Diagnosis
- Surgical Applications
By End-use (Revenue, USD Billion; 2018-2028)
- Hospitals
- Specialty clinics
- Cardiac centers
- Diagnostic centers
- Ambulatory surgical centers
- Catheterization laboratories
- Others
Request for Custom Research @ https://www.reportsanddata.com/request-customization-form/4100
By Region (Revenue, USD Billion; 2018-2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of the Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- Rest of the Middle East & Africa
Explore Reports and Data’s Prime Analysis of the global Pharmaceutical & Healthcare Industry:
Cardiac Drug Stent Market Size, Share & Analysis, By Type (Durable Polymer Drug-eluting Stents, Bioabsorbable Polymer Drug-eluting Stent), By Application (Coronary Heart Disease, Clinical, Others), And Region- Global Forecast 2020 To 2027
Cardiac Biomarkers Market Analysis, By Product Type (Troponin, Myocardial muscle Creatine Kinase, Ischemia Modified Albumin, Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome), by Location of Testing, by End user, Forecasts to 2026
Interventional Cardiology Devices Market Size, Share And Industry Analysis By Product Type (Intravascular Ultrasound (IVUS) Catheters, Stents, PTCA Guidewires, Balloon Inflation Device, PTCA Balloons), By End-use (Homecare Setting, Hospital, Ambulatory surgical centers, Clinic, Others), By Application (Coronary angioplasty, Congenital heart defect correction, Valvuloplasty, Percutaneous valve repair, Percutaneous valve replacement, Coronary thrombectomy, Others) And Region, Segment Forecasts To 2027
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read Full Press Release: https://www.reportsanddata.com/press-release/global-structural-heart-imaging-market